IN SITU FORMING HEMOSTATIC FOAM IMPLANTS
First Claim
1. A system for forming a medical implant to limit movement of a bodily fluid, comprising:
- a first chamber containing a first composition, the first composition including a polyol;
a second chamber containing a second composition, the second composition including a multifunctional isocyanate; and
a mechanism that places the first composition into contact with the second composition, thereby forming a polyurethane foam.
3 Assignments
0 Petitions
Accused Products
Abstract
Systems and methods related to polymer foams are generally described. Some embodiments relate to compositions and methods for the preparation of polymer foams, and methods for using the polymer foams. The polymer foams can be applied to a body cavity and placed in contact with, for example, tissue, injured tissue, internal organs, etc. In some embodiments, the polymer foams can be formed within a body cavity (i.e., in situ foam formation). In addition, the foamed polymers may be capable of exerting a pressure on an internal surface of a body cavity and preventing or limiting movement of a bodily fluid (e.g., blood, etc.).
23 Citations
21 Claims
-
1. A system for forming a medical implant to limit movement of a bodily fluid, comprising:
-
a first chamber containing a first composition, the first composition including a polyol; a second chamber containing a second composition, the second composition including a multifunctional isocyanate; and a mechanism that places the first composition into contact with the second composition, thereby forming a polyurethane foam. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13)
-
-
14. A system for forming a medical implant to limit movement of a bodily fluid, comprising:
-
a first chamber containing a first composition, the first composition including a polyol comprising up to 50 weight percent polyethylene oxide, up to 10 pphp of an amine catalyst, and up to 20 pphp water; a second chamber containing a second composition, the second composition including a multifunctional isocyanate; and a mechanism that places the first composition into contact with the second composition, thereby forming a polyurethane foam; wherein said foam is configured to prevent, limit, or otherwise control bleeding or the flow of bodily fluids when placed into contact with bodily tissue. - View Dependent Claims (15, 16, 17, 18, 19, 20)
-
-
21. A system for forming a medical implant to limit movement of a bodily fluid, comprising:
-
a first chamber containing a first composition, the first composition including a polyol; a second chamber containing a second composition, the second composition including a multifunctional isocyanate; a mechanism that places the first composition into contact with the second composition, thereby forming a polyurethane foam; and instructions for placing the foam into contact with bodily tissues to prevent, limit, or otherwise control bleeding or the flow of bodily fluids.
-
Specification